Trial Profile
The Effect of Remifentanil on the Reversal of Established Capsaicin-Induced Hyperalgesia in Human Volunteers.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Remifentanil (Primary)
- Indications Hyperalgesia; Pain
- Focus Therapeutic Use
- Acronyms RemiCaps2
- 24 Mar 2012 Actual end date (30 Nov 2010) added as reported by European Clinical Trials Database.
- 24 Mar 2012 Actual end date (30 Nov 2010) added as reported by European Clinical Trials Database.
- 24 Mar 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.